Atlas Trials

Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder

Clinical trial NCT01103180 · TERMINATED

Trial details

NCT number
NCT01103180
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Borderline Personality Disorder
Start date
2010-09-01
Primary completion
2014-11-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.